SR

Sumant Ramachandra

Director Director DIN 03344012
DIN 03344012 First appointment Dec 2010 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2010
Shareholding value Locked Premium profile

About Sumant Ramachandra

Data last updated:

Sumant Ramachandra has 15 years in corporate governance. Formerly with 1 company, such as Pfizer Healthcare India Private Limited. Engaged in Healthcare. Contributes to corporate operations.

DIN 03344012
Primary Designation Director
First Appointment 14 Dec 2010
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director14 Dec 20102009Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pfizer Healthcare India Private Limited
Premium access

Shareholding and investment profile for Sumant Ramachandra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumant Ramachandra

Sumant Ramachandra has 15 years in corporate governance. Formerly with 1 company, such as Pfizer Healthcare India Private Limited. Engaged in Healthcare. Contributes to corporate operations.

Sumant Ramachandra is associated with 0 companies as a director.

Sumant Ramachandra has expertise in Healthcare.

Sumant Ramachandra has 15 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available